Microarray studies have shown that the expression of S100A4 on CA-MSCs is increased in liver cancer, and it has been determined that this molecule increases the growth of liver cancer cells by increasing the expression of mir-155 and finally by activating the STAT3 pathway and becomes proliferation of these cancer cells (124). Here, S100A4 is linked to liver cancer.